Addressing cost-containment and cost-effectiveness in magnetic resonance contrast agent development.
Ashley
R A
RA
Squibb Diagnostics, Princeton, New Jersey 08543-4500.
Carvlin
M J
MJ
Lucas
T P
TP
Olukotun
A Y
AY
D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary; D003287:Contrast Media / Q000191:economics*; D003363:Cost Control; D003362:Cost-Benefit Analysis; D005682:Gadolinium; D006571:Heterocyclic Compounds; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000191:economics*; D009942:Organometallic Compounds; D014481:United States
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium